Shulman LN - Search Results

1

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Freedman RA, et al. Among authors: shulman ln. Breast Cancer Res Treat. 2017 Jan;161(2):363-373. doi: 10.1007/s10549-016-4051-1. Epub 2016 Nov 19. Breast Cancer Res Treat. 2017. PMID: 27866278 Free PMC article.

2

Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival.

Ballen KK, Gilliland DG, Kalish LA, Shulman LN. Ballen KK, et al. Among authors: shulman ln. Cancer. 1994 Jan 15;73(2):314-21. doi: 10.1002/1097-0142(19940115)73:2<314::aid-cncr2820730214>3.0.co;2-c. Cancer. 1994. PMID: 8293394

3

Continuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.

Lynch TJ Jr, Kalish LA, Kass F, Strauss G, Elias A, Skarin A, Shulman L, Sugarbaker D, Frei E. Lynch TJ Jr, et al. Cancer. 1994 Feb 15;73(4):1171-6. doi: 10.1002/1097-0142(19940215)73:4<1171::aid-cncr2820730408>3.0.co;2-l. Cancer. 1994. PMID: 8313319 Clinical Trial.

4

Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer.

Lynch TJ Jr, Kass F, Kalish LA, Elias AD, Strauss G, Shulman LN, Sugarbaker DJ, Skarin A, Frei E 3rd. Lynch TJ Jr, et al. Among authors: shulman ln. Cancer. 1993 May 15;71(10):2953-7. doi: 10.1002/1097-0142(19930515)71:10<2953::aid-cncr2820711011>3.0.co;2-j. Cancer. 1993. PMID: 8387871

5

Docetaxel administered on a weekly basis for metastatic breast cancer.

Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP. Burstein HJ, et al. Among authors: shulman ln. J Clin Oncol. 2000 Mar;18(6):1212-9. doi: 10.1200/JCO.2000.18.6.1212. J Clin Oncol. 2000. PMID: 10715290 Clinical Trial.

6

Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.

Sternberg DW, Aird W, Neuberg D, Thompson L, MacNeill K, Amrein P, Shulman LN. Sternberg DW, et al. Among authors: shulman ln. Cancer. 2000 May 1;88(9):2037-41. doi: 10.1002/(sici)1097-0142(20000501)88:9<2037::aid-cncr8>3.0.co;2-k. Cancer. 2000. PMID: 10813714

7

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.

Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP. Burstein HJ, et al. Among authors: shulman ln. J Clin Oncol. 2001 May 15;19(10):2722-30. doi: 10.1200/JCO.2001.19.10.2722. J Clin Oncol. 2001. PMID: 11352965 Clinical Trial.

8

A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.

Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht A. Bellon JR, et al. Among authors: shulman ln. Cancer. 2004 Apr 1;100(7):1358-64. doi: 10.1002/cncr.20136. Cancer. 2004. PMID: 15042668 Free article. Clinical Trial.

9

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M. Weingart SN, et al. Among authors: shulman ln. BMJ. 2007 Feb 24;334(7590):407. doi: 10.1136/bmj.39069.489757.55. Epub 2007 Jan 12. BMJ. 2007. PMID: 17223629 Free PMC article.

10

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.

Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LN. Lin NU, et al. Among authors: shulman ln. Invest New Drugs. 2007 Aug;25(4):369-75. doi: 10.1007/s10637-007-9034-y. Epub 2007 Mar 8. Invest New Drugs. 2007. PMID: 17345004 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters